Plumbline Life Sciences, Inc. (XKON:222670)
South Korea
· Delayed Price · Currency is KRW
5,170.00
-270.00 (-4.96%)
At close: Dec 4, 2025
Plumbline Life Sciences Balance Sheet
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| FY 2014 |
| Dec '14 Dec 31, 2014 |
| Cash & Equivalents | 435.61 |
| Cash & Short-Term Investments | 435.61 |
| Other Current Assets | 53.79 |
| Total Current Assets | 489.4 |
| Property, Plant & Equipment | 2.39 |
| Other Intangible Assets | 2,658 |
| Other Long-Term Assets | 8.69 |
| Accrued Expenses | 38.45 |
| Current Portion of Long-Term Debt | 1,099 |
| Other Current Liabilities | 26.32 |
| Total Current Liabilities | 1,164 |
| Pension & Post-Retirement Benefits | 11.22 |
| Other Long-Term Liabilities | 987.55 |
| Common Stock | 502.15 |
| Additional Paid-In Capital | 272.04 |
| Retained Earnings | -773.99 |
| Comprehensive Income & Other | 995.89 |
| Total Liabilities & Equity | 3,159 |
| Total Debt | 1,099 |
| Net Cash (Debt) | -663.59 |
| Net Cash Per Share | -661.02 |
| Filing Date Shares Outstanding | 1 |
| Total Common Shares Outstanding | 1 |
| Working Capital | -674.57 |
| Book Value Per Share | 992.23 |
| Tangible Book Value | -1,662 |
| Tangible Book Value Per Share | -1655.82 |
Source: S&P Capital IQ. Standard template.
Financial Sources.